Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436760 · ClinicalTrials.gov registry record
Genetic Contribution of Pain and Inflammation in IBS
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 72
- Enrollment target
NCT01436760: Completed study, sponsored by University of Florida.
NCT01436760 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01436760 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The goal of the study is to identify possible polymorphisms on the loci of candidate genes that may be involved in modulation of pain and inflammation in irritable bowel syndrome.
Primary Outcome
The goal of the study isd to identify possible polymorphisms on the loci of canidate genes that may be involved in modulation of pain and inflammation in irritable Bowel Syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-03 |
What the finished NCT01436760 record still lists
NCT01436760 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01436760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01436760 about?
NCT01436760 is a clinical study titled "Genetic Contribution of Pain and Inflammation in IBS". The goal of the study is to identify possible polymorphisms on the loci of candidate genes that may be involved in modulation of pain and inflammation in irritable bowel syndrome.
What is the current status of trial NCT01436760?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2011-05. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT01436760?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia